Integration of multi-omics data from mouse diversity panel highlights mitochondrial dysfunction in non-alcoholic fatty liver disease

KC Krishnan, Z Kurt, R Barrere-Cain, S Sabir, A Das… - Cell systems, 2018 - cell.com
The etiology of non-alcoholic fatty liver disease (NAFLD), the most common form of chronic
liver disease, is poorly understood. To understand the causal mechanisms underlying …

Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease

T Hyötyläinen, L Jerby, EM Petäjä, I Mattila… - Nature …, 2016 - nature.com
Non-alcoholic fatty liver disease (NAFLD) is a major risk factor leading to chronic liver
disease and type 2 diabetes. Here we chart liver metabolic activity and functionality in …

Utility of human relevant preclinical animal models in navigating NAFLD to MAFLD paradigm

D Chua, ZS Low, GX Cheam, AS Ng… - International Journal of …, 2022 - mdpi.com
Fatty liver disease is an emerging contributor to disease burden worldwide. The past
decades of work established the heterogeneous nature of non-alcoholic fatty liver disease …

Changes in key mitochondrial lipids accompany mitochondrial dysfunction and oxidative stress in NAFLD

M Durand, M Coué, M Croyal, T Moyon… - Oxidative medicine …, 2021 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is a dysmetabolic hepatic damage of increasing
severity: simple fat accumulation (steatosis), nonalcoholic steatohepatitis (NASH), and …

Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease

S Sookoian, CJ Pirola - PLoS One, 2013 - journals.plos.org
The abnormal accumulation of fat in the liver is often related either to metabolic risk factors
associated with metabolic syndrome in the absence of alcohol consumption (nonalcoholic …

The transcriptomic signature of disease development and progression of nonalcoholic fatty liver disease

S Cazanave, A Podtelezhnikov, K Jensen… - Scientific reports, 2017 - nature.com
A longitudinal molecular model of the development and progression of nonalcoholic fatty
liver disease (NAFLD) over time is lacking. We have recently validated a high fat/sugar water …

Transcriptional regulation in non-alcoholic fatty liver disease

S Steensels, J Qiao, BA Ersoy - Metabolites, 2020 - mdpi.com
Obesity is the primary risk factor for the pathogenesis of non-alcoholic fatty liver disease
(NAFLD), the worldwide prevalence of which continues to increase dramatically. The liver …

Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease

P Sen, O Govaere, T Sinioja, A McGlinchey, D Geng… - Iscience, 2022 - cell.com
Nonalcoholic fatty liver disease (NAFLD) is an increasingly prevalent disease that is
associated with multiple metabolic disturbances, yet the metabolic pathways underlying its …

Hepatic dysfunction caused by consumption of a high-fat diet

AR Soltis, NJ Kennedy, X Xin, F Zhou, SB Ficarro… - Cell reports, 2017 - cell.com
Obesity is a major human health crisis that promotes insulin resistance and, ultimately, type
2 diabetes. The molecular mechanisms that mediate this response occur across many highly …

Comparison of gene expression patterns between mouse models of nonalcoholic fatty liver disease and liver tissues from patients

A Teufel, T Itzel, W Erhart, M Brosch, XY Wang, YO Kim… - Gastroenterology, 2016 - Elsevier
Background & Aims Nonalcoholic fatty liver disease (NAFLD) is the most common chronic
liver disorder in industrialized countries. Mouse models of NAFLD have been used in …